SG Americas Securities
DNA icon

SG Americas Securities’s Ginkgo Bioworks DNA Stock Holding History

SG Americas Securities’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,369
Closed -$139K – 3422
2025
Q2 		$139K Sell
12,369
-17,268
-58% -$134K ﹤0.01% 2477
2025
Q1 		$169K Buy
29,637
+9,342
+46% +$95.2K ﹤0.01% 2652
2024
Q4 		$199K Buy
+20,295
New +$174K ﹤0.01% 2153
2024
Q3 		– Sell
-554
Closed -$7K – 3459
2024
Q2 		$7K Sell
554
-7
-1% -$209 ﹤0.01% 2785
2024
Q1 		$26K Sell
561
-535
-49% -$27.7K ﹤0.01% 2844
2023
Q4 		$74K Buy
1,096
+459
+72% +$28.1K ﹤0.01% 2846
2023
Q3 		$46K Sell
637
-226
-26% -$18.1K ﹤0.01% 2956
2023
Q2 		$64K Sell
863
-669
-44% -$39.6K ﹤0.01% 2122
2023
Q1 		$82K Buy
1,532
+505
+49% +$32K ﹤0.01% 2973
2022
Q4 		$69K Buy
1,027
+745
+264% +$68.5K ﹤0.01% 2799
2022
Q3 		$35K Sell
282
-149
-35% -$17.8K ﹤0.01% 3045
2022
Q2 		$41K Sell
431
-4,026
-90% -$491K ﹤0.01% 3288
2022
Q1 		$718K Buy
+4,457
New +$868K 0.01% 1648
2021
Q4 		– Sell
-3,252
Closed -$1.54M – 3480
2021
Q3 		$1.51M Buy
+3,252
New +$1.58M 0.01% 1535

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SG Americas Securities's DNA Position: Q3 2025 in Review

SG Americas Securities sold out of Ginkgo Bioworks (DNA) in Q3 2025, closing a stake of 12,369 shares — an estimated $139K sold.

SG Americas Securities first reported a position in DNA in Q3 2021 and held it in 14 quarters. The position peaked at $1.51M in Q3 2021. 174 funds tracked by Wall St. Rank hold DNA as of Q3 2025.

  • SG Americas Securities reported no remaining Ginkgo Bioworks position as of Q3 2025 after selling out during the quarter.
  • SG Americas Securities sold 12,369 Ginkgo Bioworks shares in Q3 2025, an estimated $139K.
  • SG Americas Securities first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 14 quarters.
  • SG Americas Securities's Ginkgo Bioworks position peaked at $1.51M in Q3 2021.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2025.

Based on SG Americas Securities's 13F filing for Q3 2025, filed 23 Oct 2025.